Pharmacokinetics, Tolerability, and Safety of Aripiprazole following Multiple Oral Dosing in Normal Healthy Volunteers von Mallikaarjun, Suresh, Salazar, Daniel E., Bramer, Steven L.

Volltext

Pharmacokinetic and Pharmacodynamic Interaction Between Tolvaptan, a Non-Peptide AVP Antagonist, and Furosemide or Hydrochlorothiazide von Shoaf, Susan E, Bramer, Steven L, Bricmont, Patricia, Zimmer, Christopher A

Volltext

Effects of Hepatic or Renal Impairment on the Pharmacokinetics of Aripiprazole von Mallikaarjun, Suresh, Shoaf, Susan E., Boulton, David W., Bramer, Steven L.

Volltext

A sensitive LC-MS/MS assay for the determination of dextromethorphan and metabolites in human urine—application for drug interaction studies assessing potential CYP3A and CYP2D6 in... von Vengurlekar, Shailesh S, Heitkamp, Jennifer, McCush, Fred, Velagaleti, Poonam R, Brisson, Jerry H, Bramer, Steven L

Volltext

Clinical considerations in study designs that use cotinine as a biomarker von Bramer, Steven L., Kallungal, Beatrice A.

Volltext

Method for the quantitative analysis of cilostazol and its metabolites in human plasma using LC/MS/MS von Bramer, Steven L, Tata, Prasad N.V, Vengurlekar, Shailesh S, Brisson, Jerry H

Volltext

Comparison of Two Doses and Dosing Regimens of Tolvaptan in Congestive Heart Failure von Hauptman, Paul J, Zimmer, Christopher, Udelson, James, Shoaf, Susan E, Mallikaarjun, Suresh, Bramer, Steven L, Orlandi, Cesare

Volltext

Effect of omeprazole on the metabolism of cilostazol von Suri, A, Bramer, S L

Volltext

Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics von Bramer, S L, Forbes, W P

Volltext

Extended application of an LC–MS/MS method for the analysis of vesnarinone and its metabolites in human urine and dialysate fluid von Sekar, Kumara S, Bramer, Steven L

Volltext

Determination of cilostazol and its metabolites in human urine by high performance liquid chromatography von Tata, Prasad N.V, Fu, Chau Hwei J, Bramer, Steven L

Volltext

Effects of CYP3A inhibition on the metabolism of cilostazol von Suri, A, Forbes, W P, Bramer, S L

Volltext

Effect of cilostazol on the pharmacokinetics and pharmacodynamics of warfarin von Mallikaarjun, S, Bramer, S L

Volltext

Pharmacokinetics of Multiple-Dose Oral Cilostazol in Middle-Age and Elderly Men and Women von Suri, Ajit, Forbes, William P., Bramer, Steven L.

Volltext

Interaction potential and tolerability of the coadministration of cilostazol and aspirin von Mallikaarjun, S, Forbes, W P, Bramer, S L

Volltext

The Pharmacokinetics of Toborinone in Subjects with Congestive Heart Failure and Concomitant Renal Impairment and/or Concomitant Hepatic Impairment von Tammara, Brinda, Trang, John M., Kitani, Mami, Miyamoto, Gohachiro, Bramer, Steven L.

Volltext

Effect of hepatic impairment on the pharmacokinetics of a single dose of cilostazol von Bramer, S L, Forbes, W P

Volltext

Effect of renal impairment on the pharmacokinetics of cilostazol and its metabolites von Mallikaarjun, S, Forbes, W P, Bramer, S L

Volltext

The quantitative determination of cilostazol and its four metabolites in human liver microsomal incubation mixtures by high-performance liquid chromatography von Tata, Prasad N.V, Fu, Chau-Hwei J, Browder, Norma J, Chow, Paul C, Bramer, Steven L

Volltext

The Effects of Concomitant Administration of Theophylline and Toborinone on the Pharmacokinetics of Both Compounds in Poor and Extensive Metabolizers via CYP2D6 von Tammara, Brinda, Trang, John M., Miyamoto, Gohachiro, Kitani, Mami, Brisson, Jerry, Bramer, Steven L.

Volltext